Advocacy Wealth Management Services’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1
Closed 234
2021
Q4
$0 Hold
1
﹤0.01% 201
2021
Q3
$0 Hold
1
﹤0.01% 208
2021
Q2
$0 Hold
1
﹤0.01% 212
2021
Q1
$0 Hold
1
﹤0.01% 155
2020
Q4
$0 Hold
1
﹤0.01% 151
2020
Q3
$0 Hold
1
﹤0.01% 139
2020
Q2
$0 Hold
1
﹤0.01% 143
2020
Q1
$0 Hold
1
﹤0.01% 147
2019
Q4
$0 Hold
1
﹤0.01% 163
2019
Q3
$0 Hold
1
﹤0.01% 182
2019
Q2
$0 Hold
1
﹤0.01% 181
2019
Q1
$0 Hold
1
﹤0.01% 177
2018
Q4
$0 Hold
1
﹤0.01% 178
2018
Q3
$0 Hold
1
﹤0.01% 175
2018
Q2
$0 Hold
1
﹤0.01% 203
2018
Q1
$0 Hold
1
﹤0.01% 221
2017
Q4
$0 Hold
1
﹤0.01% 261
2017
Q3
$0 Buy
+1
New +$4 ﹤0.01% 289
2017
Q2
Hold
0
307
2017
Q1
Hold
0
357
2016
Q4
Hold
0
388
2016
Q3
Hold
0
399
2016
Q2
Hold
0
469
2016
Q1
Hold
0
569
2015
Q4
Hold
0
534

Other funds holding CDMO

Advocacy Wealth Management Services's CDMO Position: Q1 2022 in Review

Advocacy Wealth Management Services sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2022, closing a stake of 1 share.

Advocacy Wealth Management Services first reported a position in CDMO in Q3 2017 and held it in 18 quarters. The position peaked at $0 in Q4 2021. 193 funds tracked by Wall St. Rank hold CDMO as of Q1 2022.

  • Advocacy Wealth Management Services reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Advocacy Wealth Management Services sold 1 Avid Bioservices, Inc. Common Stock share in Q1 2022.
  • Advocacy Wealth Management Services first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2017 and held it in 18 quarters.
  • Advocacy Wealth Management Services's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q4 2021.
  • 193 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2022.

Based on Advocacy Wealth Management Services's 13F filing for Q1 2022, filed 4 Apr 2022.